| Year |
Citation |
Score |
| 2021 |
Wang T, Perazza D, Boussouar F, Cattaneo M, Bougdour A, Chuffart F, Barral S, Vargas A, Liakopoulou A, Puthier D, Bargier L, Morozumi Y, Jamshidikia M, Garcia-Saez I, Petosa C, et al. ATAD2 controls chromatin-bound HIRA turnover. Life Science Alliance. 4. PMID 34580178 DOI: 10.26508/lsa.202101151 |
0.307 |
|
| 2020 |
Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, Monfeuga T, McDonald-McGinn DM, Gur RE, Morrow BE, Swillen A, Vorstman JAS, Bearden CE, Chow EWC, van den Bree M, ... ... Wang T, et al. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Molecular Psychiatry. PMID 32015465 DOI: 10.1038/S41380-020-0654-3 |
0.607 |
|
| 2016 |
Xie N, Gong H, Suhl JA, Chopra P, Wang T, Warren ST. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome. Plos One. 11: e0165499. PMID 27768763 DOI: 10.1371/Journal.Pone.0165499 |
0.659 |
|
| 2015 |
Cheng Y, Xie N, Jin P, Wang T. DNA methylation and hydroxymethylation in stem cells. Cell Biochemistry and Function. 33: 161-73. PMID 25776144 DOI: 10.1002/cbf.3101 |
0.473 |
|
| 2014 |
Singh AM, Chappell J, Trost R, Lin L, Wang T, Tang J, Matlock BK, Weller KP, Wu H, Zhao S, Jin P, Dalton S. Cell-Cycle Control of Developmentally Regulated Transcription Factors Accounts for Heterogeneity in Human Pluripotent Cells. Stem Cell Reports. 2: 398. PMID 28039753 DOI: 10.1016/j.stemcr.2014.02.009 |
0.427 |
|
| 2014 |
Zhu G, Li Y, Zhu F, Wang T, Jin W, Mu W, Lin W, Tan W, Li W, Street RC, Peng S, Zhang J, Feng Y, Warren ST, Sun Q, et al. Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogramming. Stem Cell Reports. 2: 253-61. PMID 24672749 DOI: 10.1016/J.Stemcr.2014.01.012 |
0.682 |
|
| 2013 |
Singh AM, Chappell J, Trost R, Lin L, Wang T, Tang J, Matlock BK, Weller KP, Wu H, Zhao S, Jin P, Dalton S. Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells. Stem Cell Reports. 1: 532-44. PMID 24371808 DOI: 10.1016/J.Stemcr.2013.10.009 |
0.446 |
|
| 2013 |
Wang T, Warren ST, Jin P. Toward pluripotency by reprogramming: mechanisms and application. Protein & Cell. 4: 820-32. PMID 24078387 DOI: 10.1007/S13238-013-3074-1 |
0.632 |
|
| 2013 |
Wang T, Wu H, Li Y, Szulwach KE, Lin L, Li X, Chen IP, Goldlust IS, Chamberlain SJ, Dodd A, Gong H, Ananiev G, Han JW, Yoon YS, Rudd MK, et al. Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency. Nature Cell Biology. 15: 700-11. PMID 23685628 DOI: 10.1038/Ncb2748 |
0.718 |
|
| 2013 |
Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, Whitaker JW, Tian S, Hawkins RD, Leung D, Yang H, Wang T, Lee AY, Swanson SA, Zhang J, et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell. 153: 1134-48. PMID 23664764 DOI: 10.1016/J.Cell.2013.04.022 |
0.315 |
|
| 2013 |
Alisch RS, Wang T, Chopra P, Visootsak J, Conneely KN, Warren ST. Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus. Bmc Medical Genetics. 14: 18. PMID 23356558 DOI: 10.1186/1471-2350-14-18 |
0.7 |
|
| 2012 |
Wang T, Pan Q, Lin L, Szulwach KE, Song CX, He C, Wu H, Warren ST, Jin P, Duan R, Li X. Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum. Human Molecular Genetics. 21: 5500-10. PMID 23042784 DOI: 10.1093/Hmg/Dds394 |
0.616 |
|
| 2012 |
Wang T, Bray SM, Warren ST. New perspectives on the biology of fragile X syndrome. Current Opinion in Genetics & Development. 22: 256-63. PMID 22382129 DOI: 10.1016/J.Gde.2012.02.002 |
0.631 |
|
| Show low-probability matches. |